184 related articles for article (PubMed ID: 32873593)
21. Pharmacokinetics of oral dichloroacetate in dogs.
Maisenbacher HW; Shroads AL; Zhong G; Daigle AD; Abdelmalak MM; Samper IS; Mincey BD; James MO; Stacpoole PW
J Biochem Mol Toxicol; 2013 Dec; 27(12):522-5. PubMed ID: 24038869
[TBL] [Abstract][Full Text] [Related]
22. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.
Saghir SA; Schultz IR
Environ Health Perspect; 2002 Aug; 110(8):757-63. PubMed ID: 12153755
[TBL] [Abstract][Full Text] [Related]
23. Chloride concentrations in human hepatic cytosol and mitochondria are a function of age.
Jahn SC; Rowland-Faux L; Stacpoole PW; James MO
Biochem Biophys Res Commun; 2015 Apr; 459(3):463-8. PubMed ID: 25748576
[TBL] [Abstract][Full Text] [Related]
24. A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats.
Jiang Y; Milavetz G; James MO; An G
J Pharm Sci; 2017 May; 106(5):1396-1404. PubMed ID: 28163135
[TBL] [Abstract][Full Text] [Related]
25. GSTZ1 expression and chloride concentrations modulate sensitivity of cancer cells to dichloroacetate.
Jahn SC; Solayman MH; Lorenzo RJ; Langaee T; Stacpoole PW; James MO
Biochim Biophys Acta; 2016 Jun; 1860(6):1202-10. PubMed ID: 26850694
[TBL] [Abstract][Full Text] [Related]
26. Perturbation of maleylacetoacetic acid metabolism in rats with dichloroacetic Acid-induced glutathione transferase zeta deficiency.
Lantum HB; Cornejo J; Pierce RH; Anders MW
Toxicol Sci; 2003 Jul; 74(1):192-202. PubMed ID: 12730618
[TBL] [Abstract][Full Text] [Related]
27. Clinical physiology and pharmacology of GSTZ1/MAAI.
Stacpoole PW
Biochem Pharmacol; 2023 Nov; 217():115818. PubMed ID: 37742772
[TBL] [Abstract][Full Text] [Related]
28. Human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate.
Shroads AL; Langaee T; Coats BS; Kurtz TL; Bullock JR; Weithorn D; Gong Y; Wagner DA; Ostrov DA; Johnson JA; Stacpoole PW
J Clin Pharmacol; 2012 Jun; 52(6):837-49. PubMed ID: 21642471
[TBL] [Abstract][Full Text] [Related]
29. Nephrotoxicity of chlorofluoroacetic acid in rats.
Lantum HB; Baggs RB; Krenitsky DM; Anders MW
Toxicol Sci; 2002 Dec; 70(2):261-8. PubMed ID: 12441371
[TBL] [Abstract][Full Text] [Related]
30. Age-Related Changes in miRNA Expression Influence GSTZ1 and Other Drug Metabolizing Enzymes.
Jahn SC; Gay LA; Weaver CJ; Renne R; Langaee TY; Stacpoole PW; James MO
Drug Metab Dispos; 2020 Jul; 48(7):563-569. PubMed ID: 32357971
[TBL] [Abstract][Full Text] [Related]
31. Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.
Dunbar EM; Coats BS; Shroads AL; Langaee T; Lew A; Forder JR; Shuster JJ; Wagner DA; Stacpoole PW
Invest New Drugs; 2014 Jun; 32(3):452-64. PubMed ID: 24297161
[TBL] [Abstract][Full Text] [Related]
32. Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans.
Shroads AL; Coats BS; Langaee T; Shuster JJ; Stacpoole PW
Drug Metab Pers Ther; 2015 Mar; 30(1):49-55. PubMed ID: 25283137
[TBL] [Abstract][Full Text] [Related]
33. Mass spectral characterization of dichloroacetic acid-modified human glutathione transferase zeta.
Anderson WB; Liebler DC; Board PG; Anders MW
Chem Res Toxicol; 2002 Nov; 15(11):1387-97. PubMed ID: 12437329
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and Biochemical Profiling of Sodium Dichloroacetate in Pregnant Ewes and Fetuses.
Joseph S; Sharma A; Horne LP; Wood CE; Langaee T; James MO; Stacpoole PW; Keller-Wood M
Drug Metab Dispos; 2020 Jun; 49(6):451-458. PubMed ID: 33811107
[TBL] [Abstract][Full Text] [Related]
35. Peripheral neuropathy in rats exposed to dichloroacetate.
Calcutt NA; Lopez VL; Bautista AD; Mizisin LM; Torres BR; Shroads AL; Mizisin AP; Stacpoole PW
J Neuropathol Exp Neurol; 2009 Sep; 68(9):985-93. PubMed ID: 19680144
[TBL] [Abstract][Full Text] [Related]
36. The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?
Stacpoole PW
Environ Health Perspect; 2011 Feb; 119(2):155-8. PubMed ID: 20920954
[TBL] [Abstract][Full Text] [Related]
37. Dichloroacetate-induced peripheral neuropathy.
Stacpoole PW; Martyniuk CJ; James MO; Calcutt NA
Int Rev Neurobiol; 2019; 145():211-238. PubMed ID: 31208525
[TBL] [Abstract][Full Text] [Related]
38. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice.
Larson JL; Bull RJ
Toxicol Appl Pharmacol; 1992 Aug; 115(2):268-77. PubMed ID: 1641860
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate.
Tzeng HF; Blackburn AC; Board PG; Anders MW
Chem Res Toxicol; 2000 Apr; 13(4):231-6. PubMed ID: 10775321
[TBL] [Abstract][Full Text] [Related]
40. Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats.
James MO; Cornett R; Yan Z; Henderson GN; Stacpoole PW
Drug Metab Dispos; 1997 Nov; 25(11):1223-7. PubMed ID: 9351896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
